Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer
Clinical trial NCT04379739 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04379739
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-26
- Primary completion
- 2022-06-29
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.